<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01175863</url>
  </required_header>
  <id_info>
    <org_study_id>FAVOR</org_study_id>
    <nct_id>NCT01175863</nct_id>
  </id_info>
  <brief_title>Fractional Flow Reserve (FFR) Versus Intravascular Ultrasound (IVUS) in Intermediate Coronary Artery Disease</brief_title>
  <acronym>FAVOR</acronym>
  <official_title>Fractional Flow Reserve- And Intra-vascular Ultrasound-Guided Percutaneous Coronary Intervention With Drug-Eluting Stents in Intermediate Coronary Artery Lesion (FAVOR Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ajou University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ajou University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a prospective, randomized, multi-center, open label trial to compare the
      clinical outcomes and effectiveness of Intravascular ultrasound (IVUS) versus Fractional Flow
      Reserve (FFR) guided Percutaneous coronary intervention (PCI) with intermediate coronary
      artery lesion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This trial is a prospective, randomized, open label, two arm designed multi-center trial.
      When diagnostic coronary angiogram shows that the target lesion is intermediate stenosis,
      IVUS and/or FFR will be performed in order to decide PCI or defer by 1:1 randomization. The
      patients would be followed up to 2 years clinically.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Anticipated">May 2014</completion_date>
  <primary_completion_date type="Anticipated">May 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac events (composite of cardiac death, myocardial infarction and target vessel revascularization)</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction (MI)</measure>
    <time_frame>1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Composite of cardiac death or myocardial infarction</measure>
    <time_frame>1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization (ischemia- and clinically-driven)</measure>
    <time_frame>1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization (ischemia- and clinically-driven)</measure>
    <time_frame>1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis (Academic Research Consortium criteria)</measure>
    <time_frame>1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-stent and in-segment late loss on angiographic follow-up</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-stent and in-segment restenosis rate</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence and angiographic pattern of restenosis</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Canadian Cardiovascular Society Classification status</measure>
    <time_frame>1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number of anti-angina medication</measure>
    <time_frame>1 and 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of percutaneous coronary intervention at intravascular ultrasound and fractional flow reserve-guided group</measure>
    <time_frame>Baseline (day 0)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major adverse cardiac events (composite of cardiac death, myocardial infarction and target vessel revascularization)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1400</enrollment>
  <condition>Coronary Artery Stenosis</condition>
  <arm_group>
    <arm_group_label>Intravascular ultrasound</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Fractional flow reserve</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Grey scale intravascular ultrasound (Galaxy or Virtual histology-Intravascular Ultrasound)</intervention_name>
    <description>minimal lumen area on Intravascular ultrasound</description>
    <arm_group_label>Intravascular ultrasound</arm_group_label>
    <other_name>Galaxy (Boston Scientific)</other_name>
    <other_name>Virtual histology (Volcano)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pressure wire(Radi Medical Systems)</intervention_name>
    <description>Fractional flow reserve measured by pressure wire</description>
    <arm_group_label>Fractional flow reserve</arm_group_label>
    <other_name>Pressure wire (Radi Medical Systems)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical indication:

          -  Patients with angina or patients with documented silent ischemia

          -  Patients who are eligible for intracoronary stenting

          -  Age &gt; 18 years old, &lt; 75 years old

        Angiographic indication:

          -  Intermediate coronary artery disease (30-70% diameter stenosis) by visual estimation

          -  Reference vessel diameter ≥ 3.0mm by visual estimation

        Exclusion Criteria:

          -  Acute or old myocardial infarction

          -  Previous coronary artery bypass graft

          -  Left main disease (≥ 50% stenosis)

          -  In-stent restenosis lesion

          -  Chronic total occlusion

          -  Low ejection fraction (&lt; 40 %)

          -  Graft vessel lesion

          -  History of bleeding diathesis or coagulopathy

          -  Limited life-expectancy (less than 1 year) due to combined serious disease

          -  Contra-indication to heparin, everolimus

          -  Contraindication to aspirin, clopidogrel or cilostazol

          -  Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sejung-Jea Tahk, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ajou University Medical Center, Ajou University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Keimyung university Dongsan medical center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inje University</name>
      <address>
        <city>Ilsan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Korea University Guro Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul National University Boramae Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seoul national university hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yensei University Gangnam Severance Hospital</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ajou University Medical Center</name>
      <address>
        <city>Suwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yeonsei Univeristy Wonju College of Medicine Wonju Christion Hospital</name>
      <address>
        <city>Wonju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2010</study_first_submitted>
  <study_first_submitted_qc>August 4, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2010</study_first_posted>
  <last_update_submitted>February 11, 2014</last_update_submitted>
  <last_update_submitted_qc>February 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 12, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ajou University School of Medicine</investigator_affiliation>
    <investigator_full_name>Seung-Jea Tahk</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>intravascular ultrasound</keyword>
  <keyword>fractional flow reserve</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

